Trevi Therapeutics, Inc. - Common Stock (TRVI)
CUSIP: 89532M101
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 128,120,714
- Total 13F shares
- 14,115,568
- Share change
- -50,664
- Total reported value
- $63,519,000
- Price per share
- $4.50
- Number of holders
- 17
- Value change
- -$267,929
- Number of buys
- 6
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. |
13F
|
Company |
4.9%
|
6,324,319
|
$47,432,000 | — | 30 Jun 2019 | |
| NEA Management Company, LLC |
13F
|
Company |
3.5%
|
4,429,804
|
$33,224,000 | — | 30 Jun 2019 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.99%
|
1,263,408
|
$9,476,000 | — | 30 Jun 2019 | |
| FMR LLC |
13F
|
Company |
0.62%
|
792,700
|
$5,945,000 | — | 30 Jun 2019 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.55%
|
700,000
|
$5,250,000 | — | 30 Jun 2019 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.18%
|
234,442
|
$1,759,000 | — | 30 Jun 2019 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.1%
|
125,000
|
$938,000 | — | 30 Jun 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.09%
|
118,091
|
$886,000 | — | 30 Jun 2019 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.08%
|
100,119
|
$751,000 | — | 30 Jun 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
41,482
|
$311,000 | — | 30 Jun 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
16,480
|
$124,000 | — | 30 Jun 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
12,300
|
$92,000 | — | 30 Jun 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
5,659
|
$42,000 | — | 30 Jun 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
3,484
|
$26,000 | — | 30 Jun 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,921
|
$14,000 | — | 30 Jun 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,202
|
$9,000 | — | 30 Jun 2019 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
850
|
$6,000 | — | 30 Jun 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
630
|
$5,000 | — | 30 Jun 2019 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock (TRVI) as of Q3 2019
As of 30 Sep 2019,
Trevi Therapeutics, Inc. - Common Stock (TRVI) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,115,568 shares.
The largest 10 holders included
TPG Group Holdings (SBS) Advisors, Inc., NEA Management Company, LLC, Omega Fund Management, LLC, FMR LLC, FRANKLIN RESOURCES INC, Schonfeld Strategic Advisors LLC, VANGUARD GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, Alyeska Investment Group, L.P., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
18
Q3 2019 holders
17
Holder diff
-1
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.